查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1772237

全球多体学服务市场：市场规模、份额、趋势分析（按服务、类型、应用、最终用途和地区）、细分市场预测（2025-2033）

Multiomics Services Market Size, Share & Trends Analysis Report By Service (Research, Data Analysis), By Type (Single-cell Multiomics, Bulk Multiomics), By Application, By End-use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

多组体学服务市场成长与趋势：

根据Grand View Research, Inc.的最新报告，全球多组体学服务市场预计到2033年将达到47.2亿美元，2025年至2033年期间的复合年增长率为17.41%。

多体学服务产业正经历加速成长，这得益于对整合生物数据日益增长的需求，这些数据旨在实现精准医疗、高阶诊断和系统生物学研究。随着对复杂生物机制理解需求的不断增长，结合基因组学、转录组学、蛋白质组学、代谢体学和表观基因的多组体学正成为全面发现生物标记、疾病分层和开发疗法的重要工具。

製药和生物技术公司、研究机构和临床实验室越来越多地利用多体学平台来深入了解疾病路径、治疗标靶和患者特异性反应。策略联盟、不断增加的研发投入以及技术融合正在推动多组体学服务的创新，同时提高跨组体学层面的数据整合和可解释性。

多组体学在肿瘤学、免疫学、神经病学和感染疾病研究中的应用日益广泛，进一步推动了市场扩张。在资料品质、隐私和临床检验法律规范日益严格的背景下，服务供应商正在投资强大的品管系统、安全的资料管理解决方案和人工智慧主导的分析技术，以满足不断变化的客户和合规性需求。多体学服务透过提供对生物系统和疾病进展的整体情况，正在重塑转化医学和个人化医疗的未来。

随着体学技术的快速发展和对精准洞察的需求不断增长，多体学服务市场有望成为下一代生物医学创新和全球健康转型的基石。

多组体学服务市场：分析概述

  • 预计研究服务领域将在2024年占据最大的市场收益占有率。这一领先地位源于其在支持临床前试验、机制研究和早期药物发现方面发挥的重要作用。随着多体学方法成为理解复杂疾病生物学的关键，学术和商业性研究的需求只会不断增长。
  • 由于大量多体学学在大规模研究中的广泛应用，以及基因组学、转录组学和蛋白质组学领域已建立的工作流程，预计批量多组学将在2024年占据最大的市场收益占有率。这些方法广泛应用于群体层级的生物标记发现、疾病分析和标靶验证。单细胞定序技术的进步持续推动其在肿瘤学、免疫学和神经科学研究领域的应用。
  • 受对整合资料日益增长的需求推动，药物发现和开发领域旨在加速目标识别和简化研发流程，该领域在 2024 年占据市场最大收入份额，达到 35.45%。然而，合成生物学领域预计将以最快的速度成长，预测期内的复合年增长率为 19.40%。
  • 2024年，製药和生物技术领域占据了最大的市场收益占有率。这些机构正在将多组体学纳入其研发工作流程，以加速精准药物开发、伴随委外研发机构和疗法优化。与合约研究组织（CRO）和多组体学平台提供者日益增多的合作也为此领域提供了支持。
  • 北美占据市场主导地位，2024年其收益占有率最高，达到40.13%，这得益于其先进的医疗基础设施、雄厚的基因组学研究资金以及体学技术的早期应用。然而，预计亚太地区在预测期内的复合年增长率最高，达19.62%。
  • 2025年1月，NVIDIA宣布与IQVIA、Illumina、梅奥诊所和Ark Research Institute建立策略伙伴关係，以彻底改变基因组学、药物研发和医疗保健领域。这些合作将专注于开发用于加速临床试验的AI代理、用于药物研发和数位病理学的AI模型，以及用于手术和病患监测的实体AI机器人。

目录

第一章 分析方法与范围

第二章执行摘要

第三章 市场驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 多组体学服务市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章 多体学服务市场：按服务分類的业务分析

  • 细分仪表板：依服务
  • 全球多组体学服务市场：变异分析（按服务）
  • 全球多组体学服务市场规模及趋势分析（按服务划分）（2021-2033）
  • 研究服务
  • 数据分析服务

第五章多体学服务市场：按类型分類的业务分析

  • 细分仪表板：按类型
  • 全球多体学服务市场：变异分析（按类型）
  • 全球多组体学服务市场规模及趋势分析（按类型）（2021-2033）
  • 单细胞多组体学
  • 批量体学

第六章多组体学服务市场：按应用进行的业务分析

  • 细分仪表板：依用途
  • 全球多体学服务市场：变异分析（按应用）
  • 全球多体学服务市场规模与应用趋势分析（2021-2033）
  • 生物标记发现
  • 药物研发
  • 合成生物学
  • 其他的

7. 多组体学服务市场：依最终用途进行的业务分析

  • 细分仪表板：依最终用途
  • 全球多体学服务市场（按变异分析和最终用途）
  • 全球多组体学服务市场规模和趋势分析（按最终用途）（2021-2033）
  • 製药和生物技术公司
  • 学术研究所
  • 其他的

第八章 多组体学服务市场：按地区估计和趋势分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 泰国
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第九章 竞争态势

  • 公司分类
  • 战略地图
  • 企业市场分析（2024年）
  • 公司简介/上市公司
    • Bio-Techne
    • CD Genomics
    • RayBiotech, Inc.
    • . Creative Proteomics
    • Psomagen
    • Source BioScience
    • Persistent Systems
    • Metware Biotechnology Inc.
    • Dalton Bioanalytics Inc.
    • Sapient Bioanalytics, LLC.
Product Code: GVR-4-68040-640-2

Multiomics Services Market Growth & Trends:

The global multiomics services market size is projected to reach USD 4.72 billion by 2033, growing at a CAGR of 17.41% from 2025 to 2033, according to a new report by Grand View Research, Inc. The multiomics services industry is witnessing accelerated growth, driven by the increasing demand for integrated biological data to enable precision medicine, advanced diagnostics, and systems biology research. As the need to understand complex biological mechanisms intensifies, multiomics approaches combining genomics, transcriptomics, proteomics, metabolomics, and epigenomics are becoming essential tools for comprehensive biomarker discovery, disease stratification, and therapeutic development.

Pharmaceutical and biotechnology companies, research institutions, and clinical laboratories increasingly leverage multiomics platforms to gain deeper insights into disease pathways, therapeutic targets, and patient-specific responses. Strategic collaborations, rising R&D investments, and technological convergence catalyze innovation in multiomics service offerings while enhancing data integration and interpretability across diverse omics layers.

The growing adoption of multiomics in oncology, immunology, neurology, and infectious disease research further fueled the market's expansion. As regulatory frameworks around data quality, privacy, and clinical validation tighten, service providers invest in robust quality control systems, secure data management solutions, and AI-driven analytics to meet evolving customer and compliance needs. Multiomics services are reshaping the future of translational medicine and individualized healthcare by offering holistic views of biological systems and disease progression.

With the rapid evolution of omics technologies and the growing demand for precision insights, the multiomics services market is positioned to become a cornerstone of next-generation biomedical innovation and global health transformation.

Multiomics Services Market Report Highlights:

  • The research services segment accounted for the largest market revenue share in 2024. This leadership derives from their foundational role in supporting preclinical studies, mechanistic research, and early-stage drug discovery. As multiomics approaches become integral to understanding complex disease biology, academic and commercial research demand continues to rise.
  • The bulk multiomics segment accounted for the largest market revenue share in 2024, owing to its widespread adoption in large-scale studies and established workflows in genomics, transcriptomics, and proteomics. These approaches are widely used in population-level biomarker discovery, disease profiling, and target validation. Advances in single cell sequencing technologies continue to drive adoption across oncology, immunology, and neuroscience research.
  • The drug discovery & development segment led the market with the largest revenue share of 35.45% in 2024, driven by the growing need for integrated data to accelerate target identification and streamline R&D. However, the synthetic biology segment is expected to grow at the fastest CAGR of 19.40% over the forecast period.
  • The pharmaceutical and biotechnology segment accounted for the largest market revenue share in 2024. These organizations integrate multiomics into R&D workflows to accelerate precision drug development, companion diagnostics, and therapeutic optimization. Increasing collaborations with contract research organizations (CROs) and multiomics platform providers support this segment.
  • North America dominated the market with the largest revenue share of 40.13% in 2024. This is attributed to advanced healthcare infrastructure, strong genomics research funding, and early adoption of omics technologies. However, Asia Pacific is expected to grow at the highest CAGR of 19.62% over the forecast period.
  • In January 2025, NVIDIA announced strategic partnerships with IQVIA, Illumina, Mayo Clinic, and Arc Institute to revolutionize genomics, drug discovery, and healthcare. The initiatives focus on developing AI agents to expedite clinical trials, AI models for drug discovery and digital pathology, and physical AI robots for surgery and patient monitoring.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Service Segment
    • 1.2.2. Type Segment
    • 1.2.3. Application Segment
    • 1.2.4. End Use Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Multiomics Services Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Multiomics Services Market: Service Business Analysis

  • 4.1. Service Segment Dashboard
  • 4.2. Global Multiomics Services Market Service Movement Analysis
  • 4.3. Global Multiomics Services Market Size & Trend Analysis, by Service, 2021 to 2033 (USD Million)
  • 4.4. Research Services
    • 4.4.1. Global Research Services based Market, 2021 - 2033 (USD Million)
  • 4.5. Data Analysis Services
    • 4.5.1. Global Data Analysis Services Market, 2021 - 2033 (USD Million)

Chapter 5. Multiomics Services Market: Type Business Analysis

  • 5.1. Type Segment Dashboard
  • 5.2. Global Multiomics Services Market Type Movement Analysis
  • 5.3. Global Multiomics Services Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 5.4. Single-cell Multiomics
    • 5.4.1. Global Single-cell Multiomics Market, 2021 - 2033 (USD Million)
  • 5.5. Bulk Multiomics
    • 5.5.1. Global Bulk Multiomics Market, 2021 - 2033 (USD Million)

Chapter 6. Multiomics Services Market: Application Business Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Global Multiomics Services Market Application Movement Analysis
  • 6.3. Global Multiomics Services Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Biomarker Discovery Market
    • 6.4.1. Global Biomarker Discovery Market, 2021 - 2033 (USD Million)
  • 6.5. Drug Discovery & Development
    • 6.5.1. Global Drug Discovery & Development Market, 2021 - 2033 (USD Million)
  • 6.6. Synthetic Biology
    • 6.6.1. Global Synthetic Biology Market, 2021 - 2033 (USD Million)
  • 6.7. Others
    • 6.7.1. Global Others Market, 2021 - 2033 (USD Million)

Chapter 7. Multiomics Services Market: End Use Business Analysis

  • 7.1. End Use Segment Dashboard
  • 7.2. Global Multiomics Services Market End Use Movement Analysis
  • 7.3. Global Multiomics Services Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 7.4. Pharmaceutical and Biotechnology Companies
    • 7.4.1. Global Pharmaceutical and Biotechnology Companies Devices Market, 2021 - 2033 (USD Million)
  • 7.5. Academic & Research Institutes
    • 7.5.1. Global Academic & Research Institutes Market, 2021 - 2033 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Others Market, 2021 - 2033 (USD Million)

Chapter 8. Regional Multiomics Services Market: Region Estimates & Trend Analysis

  • 8.1. North America
    • 8.1.1. North America market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.1.2. U.S.
      • 8.1.2.1. Key country dynamics
      • 8.1.2.2. Competitive scenario
      • 8.1.2.3. Regulatory Framework
      • 8.1.2.4. Target Disease Prevalence
      • 8.1.2.5. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.1.3. Canada
      • 8.1.3.1. Key country dynamics
      • 8.1.3.2. Competitive scenario
      • 8.1.3.3. Regulatory Framework
      • 8.1.3.4. Target Disease Prevalence
      • 8.1.3.5. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.1.4. Mexico
      • 8.1.4.1. Key country dynamics
      • 8.1.4.2. Competitive scenario
      • 8.1.4.3. Regulatory Framework
      • 8.1.4.4. Target Disease Prevalence
      • 8.1.4.5. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.2. Europe
    • 8.2.1. Europe market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.2.2. UK
      • 8.2.2.1. Key country dynamics
      • 8.2.2.2. Competitive scenario
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Target Disease Prevalence
      • 8.2.2.5. UK market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.2.3. Germany
      • 8.2.3.1. Key country dynamics
      • 8.2.3.2. Competitive scenario
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Target Disease Prevalence
      • 8.2.3.5. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.2.4. France
      • 8.2.4.1. Key country dynamics
      • 8.2.4.2. Competitive scenario
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Target Disease Prevalence
      • 8.2.4.5. France market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.2.5. Italy
      • 8.2.5.1. Key country dynamics
      • 8.2.5.2. Competitive scenario
      • 8.2.5.3. Regulatory Framework
      • 8.2.5.4. Target Disease Prevalence
      • 8.2.5.5. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.2.6. Spain
      • 8.2.6.1. Key country dynamics
      • 8.2.6.2. Competitive scenario
      • 8.2.6.3. Regulatory Framework
      • 8.2.6.4. Target Disease Prevalence
      • 8.2.6.5. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.2.7. Norway
      • 8.2.7.1. Key country dynamics
      • 8.2.7.2. Competitive scenario
      • 8.2.7.3. Regulatory Framework
      • 8.2.7.4. Target Disease Prevalence
      • 8.2.7.5. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.2.8. Sweden
      • 8.2.8.1. Key country dynamics
      • 8.2.8.2. Competitive scenario
      • 8.2.8.3. Regulatory Framework
      • 8.2.8.4. Target Disease Prevalence
      • 8.2.8.5. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.2.9. Denmark
      • 8.2.9.1. Key country dynamics
      • 8.2.9.2. Competitive scenario
      • 8.2.9.3. Regulatory Framework
      • 8.2.9.4. Target Disease Prevalence
      • 8.2.9.5. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.3. Asia Pacific
    • 8.3.1. Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. Japan
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Competitive scenario
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Target Disease Prevalence
      • 8.3.2.5. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. China
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Competitive scenario
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Target Disease Prevalence
      • 8.3.3.5. China market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. India
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Competitive scenario
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Target Disease Prevalence
      • 8.3.4.5. India market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.5. Thailand
      • 8.3.5.1. Key country dynamics
      • 8.3.5.2. Competitive scenario
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Target Disease Prevalence
      • 8.3.5.5. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.6. South Korea
      • 8.3.6.1. Key country dynamics
      • 8.3.6.2. Competitive scenario
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Target Disease Prevalence
      • 8.3.6.5. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.7. Australia
      • 8.3.7.1. Key country dynamics
      • 8.3.7.2. Competitive scenario
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Target Disease Prevalence
      • 8.3.7.5. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4. Latin America
    • 8.4.1. Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. Brazil
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Target Disease Prevalence
      • 8.4.2.5. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Argentina
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Target Disease Prevalence
      • 8.4.3.5. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Middle East & Africa
    • 8.5.1. Middle East & Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. South Africa
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Target Disease Prevalence
      • 8.5.2.5. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Saudi Arabia
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Target Disease Prevalence
      • 8.5.3.5. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. UAE
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Target Disease Prevalence
      • 8.5.4.5. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Kuwait
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory Framework
      • 8.5.5.4. Target Disease Prevalence
      • 8.5.5.5. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. Company Profiles/Listing
    • 9.4.1. Bio-Techne
      • 9.4.1.1. Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Service Benchmarking
      • 9.4.1.4. Strategic Initiatives
    • 9.4.2. CD Genomics
      • 9.4.2.1. Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Service Benchmarking
      • 9.4.2.4. Strategic Initiatives
    • 9.4.3. RayBiotech, Inc.
      • 9.4.3.1. Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Service Benchmarking
      • 9.4.3.4. Strategic Initiatives
    • 9.4.4. . Creative Proteomics
      • 9.4.4.1. Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Service Benchmarking
      • 9.4.4.4. Strategic Initiatives
    • 9.4.5. Psomagen
      • 9.4.5.1. Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Service Benchmarking
      • 9.4.5.4. Strategic Initiatives
    • 9.4.6. Source BioScience
      • 9.4.6.1. Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Service Benchmarking
      • 9.4.6.4. Strategic Initiatives
    • 9.4.7. Persistent Systems
      • 9.4.7.1. Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Service Benchmarking
      • 9.4.7.4. Strategic Initiatives
    • 9.4.8. Metware Biotechnology Inc.
      • 9.4.8.1. Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Service Benchmarking
      • 9.4.8.4. Strategic Initiatives
    • 9.4.9. Dalton Bioanalytics Inc.
      • 9.4.9.1. Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Service Benchmarking
      • 9.4.9.4. Strategic Initiatives
    • 9.4.10. Sapient Bioanalytics, LLC.
      • 9.4.10.1. Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Service Benchmarking
      • 9.4.10.4. Strategic Initiatives

List of Tables

  • Table 1 North America multiomics services market estimates & forecasts
  • Table 2 North America multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 3 North America multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 4 North America multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 5 North America multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 6 U.S. multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 7 U.S. multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 8 U.S. multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 9 U.S. multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 10 Canada multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 11 Canada multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 12 Canada multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 13 Canada multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 14 Mexico multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 15 Mexico multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 16 Mexico multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 17 Mexico multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 18 Europe multiomics services market estimates & forecasts
  • Table 19 Europe multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 20 Europe multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 21 Europe multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 22 Europe multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 23 UK multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 24 UK multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 25 UK multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 26 UK multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 27 Germany multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 28 Germany multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 29 Germany multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 30 Germany multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 31 France multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 32 France multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 33 France multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 34 France multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 35 Spain multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 36 Spain multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 37 Spain multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 38 Spain multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 39 Italy multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 40 Italy multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 41 Italy multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 42 Italy multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 43 Denmark multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 44 Denmark multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 45 Denmark multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 46 Denmark multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 47 Sweden multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 48 Sweden multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 49 Sweden multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 50 Sweden multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 51 Norway multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 52 Norway multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 53 Norway multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 54 Norway multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 55 Asia Pacific multiomics services market estimates & forecasts
  • Table 56 Asia Pacific multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 60 China multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 61 China multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 62 China multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 63 China multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 64 Japan multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 65 Japan multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 66 Japan multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 67 Japan multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 68 India multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 69 India multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 70 India multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 71 India multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 72 South Korea multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 73 South Korea multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 74 South Korea multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 75 South Korea multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 76 Australia multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 77 Australia multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 78 Australia multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 79 Australia multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 80 Thailand multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 81 Thailand multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 82 Thailand multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 83 Thailand multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 84 Latin America multiomics services market estimates & forecasts
  • Table 85 Latin America multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 86 Latin America multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 87 Latin America multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 88 Latin America multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 89 Brazil multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 90 Brazil multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 91 Brazil multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 92 Brazil multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 93 Argentina multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 94 Argentina multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 95 Argentina multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 96 Argentina multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 97 MEA multiomics services market estimates & forecasts
  • Table 98 MEA multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 99 MEA multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 100 MEA multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 101 MEA multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 102 South Africa multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 103 South Africa multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 104 South Africa multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 105 South Africa multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 106 Saudi Arabia multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 107 Saudi Arabia multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 108 Saudi Arabia multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 110 UAE multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 111 UAE multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 112 UAE multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 113 UAE multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 114 Kuwait multiomics services market estimates & forecasts, by service, 2021 - 2033 (USD Million)
  • Table 115 Kuwait multiomics services market estimates & forecasts, by type, 2021 - 2033 (USD Million)
  • Table 116 Kuwait multiomics services market estimates & forecasts, by application, 2021 - 2033 (USD Million)
  • Table 117 Kuwait multiomics services market estimates & forecasts, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market snapshot
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market trends & outlook
  • Fig. 7 Market segmentation & scope
  • Fig. 8 Market driver relevance analysis (Current & future impact)
  • Fig. 9 Market restraint relevance analysis (Current & future impact)
  • Fig. 10 PESTLE Analysis
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Strategy framework
  • Fig. 13 Participant categorization
  • Fig. 14 Multiomics Services market: Service outlook key takeaways
  • Fig. 15 Multiomics Services market: Service movement analysis
  • Fig. 16 Research Services market, 2021 - 2033 (USD million)
  • Fig. 17 Data Analysis Services market, 2021 - 2033 (USD million)
  • Fig. 18 Multiomics Services market: Type outlook key takeaways
  • Fig. 19 Multiomics Services market: Type movement analysis
  • Fig. 20 Single-cell Multiomics market, 2021 - 2033 (USD million)
  • Fig. 21 Bulk Multiomics market, 2021 - 2033 (USD million)
  • Fig. 22 Multiomics Services market: Application outlook key takeaways
  • Fig. 23 Multiomics Services market: Application movement analysis
  • Fig. 24 Biomarker Discovery market, 2021 - 2033 (USD million)
  • Fig. 25 Drug Discovery & Development market, 2021 - 2033 (USD million)
  • Fig. 26 Synthetic Biology market, 2021 - 2033 (USD million)
  • Fig. 27 Others market, 2021 - 2033 (USD million)
  • Fig. 28 Multiomics Services market: End Use outlook key takeaways
  • Fig. 29 Multiomics Services market: End Use movement analysis
  • Fig. 30 Academic & Research Institutes market, 2021 - 2033 (USD Million)
  • Fig. 31 Pharmaceutical and Biotechnology Companies market, 2021 - 2033 (USD Million)
  • Fig. 32 Others market, 2021 - 2033 (USD Million)
  • Fig. 33 Multiomics Services market, by region, 2021 - 2033 (USD Million)
  • Fig. 34 North America multiomics services market, by country, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 36 Canada multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 37 Mexico multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 38 Europe multiomics services market, by country, 2021 - 2033 (USD Million)
  • Fig. 39 UK multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 40 Germany multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 41 France multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 42 Italy multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 43 Spain multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 44 Denmark multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 45 Sweden multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 46 Norway multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 47 Asia Pacific multiomics services market, by country, 2021 - 2033 (USD Million)
  • Fig. 48 Japan multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 49 China multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 50 India multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 51 Australia multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 52 South Korea multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 53 Thailand multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 54 Latin America multiomics services market, by country, 2021 - 2033 (USD Million)
  • Fig. 55 Brazil multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 56 Argentina multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 57 Middle East & Africa multiomics services market, by country, 2021 - 2033 (USD Million)
  • Fig. 58 South Africa multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 59 Saudi Arabia multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 60 UAE multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 61 Kuwait multiomics services market, 2021 - 2033 (USD Million)
  • Fig. 62 Key companies profiled